Livalo and Enbrel drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Livalo (pitavastatin calcium) and Enbrel (etanercept). Common drug interactions include injection site pain among females and pneumocystis jiroveci pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Livalo and Enbrel. It is created by eHealthMe based on reports of 95 people who take the same drugs from the FDA, and is updated regularly.

What is Livalo?

Livalo has active ingredients of pitavastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 8,802 Livalo users. Check the latest studies of Livalo.

What is Enbrel?

Enbrel has active ingredients of etanercept. It is often used in rheumatoid arthritis. eHealthMe is studying from 664,678 Enbrel users. Check the latest studies of Enbrel.



On Aug, 03, 2026

95 people who take Livalo and Enbrel together, and have interactions are studied.

Livalo and Enbrel drug interactions.

What are the common drug interactions of Livalo and Enbrel, by gender? *:

female:

  1. Injection site pain
  2. Liver disorder (liver diseases)
  3. Lymphopenia (an abnormally low level of lymphocytes in the blood)
  4. Malaise (a feeling of general discomfort or uneasiness)
  5. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  6. Psoriasis (immune-mediated disease that affects the skin)
  7. Sarcoidosis (an inflammatory disease that affects multiple organs in the body, but mostly the lungs and lymph glands)
  8. White blood cell count increased
  9. Administration site reaction
  10. Anaemia (lack of blood)

male:

  1. Pneumocystis jiroveci pneumonia (fungal infection of the lungs)
  2. Drug ineffective
  3. Nasopharyngitis (inflammation of the nasopharynx)
  4. Squamous cell carcinoma (a cancer of a kind of epithelial cell)
  5. Walking disability
  6. Alopecia (absence of hair from areas of the body)
  7. Aspartate aminotransferase increased
  8. Chronic kidney disease
  9. Cough
  10. Gait disturbance

What are the common drug interactions of Livalo and Enbrel, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Diarrhoea
  2. Influenza
  3. Injection site pruritus (severe itching at injection site)
  4. Injection site swelling
  5. Nasopharyngitis (inflammation of the nasopharynx)
  6. Rectal haemorrhage (bleeding from anus)

50-59:

  1. Swelling
  2. Psoriasis (immune-mediated disease that affects the skin)
  3. Sarcoidosis (an inflammatory disease that affects multiple organs in the body, but mostly the lungs and lymph glands)
  4. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  5. Asthenia (weakness)
  6. Cough
  7. Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
  8. Erythema (redness of the skin)
  9. Gait disturbance
  10. Hypoaesthesia (reduced sense of touch or sensation)

60+:

  1. Cellulitis (infection under the skin)
  2. Peripheral swelling
  3. Purpura (purplish discoloration of the skin)
  4. Fall
  5. Sepsis (a severe blood infection that can lead to organ failure and death)
  6. Spinal compression fracture (fracture due to spinal compression on bone)
  7. Muscle spasms (muscle contraction)
  8. Nasopharyngitis (inflammation of the nasopharynx)
  9. Pain in extremity
  10. Pneumocystis jiroveci pneumonia (fungal infection of the lungs)

What are the existing conditions these people have? *

  1. Hyperlipidaemia (presence of excess lipids in the blood): 12 people, 12.63%
  2. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 10 people, 10.53%
  3. Psoriasis (immune-mediated disease that affects the skin): 9 people, 9.47%
  4. Diabetes: 9 people, 9.47%
  5. Osteoporosis (bones weak and more likely to break): 5 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Livalo and Enbrel?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Livalo and Enbrel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Livalo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Enbrel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Livalo and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Enbrel and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on pitavastatin calcium and etanercept (the active ingredients of Livalo and Enbrel, respectively), and Livalo and Enbrel (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: